Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia.

Haematologica
Yuzhe ShiFrederik W van Delft

Abstract

T-cell Acute Lymphoblastic Leukemia (T-ALL) is frequently characterized by glucocorticoid (GC) resistance, which is associated with inferior outcomes, thus highlighting the need for novel therapeutic approaches for GC resistant T-ALL. The pTCR/TCR signaling pathways play a critical role in cell fate decisions during physiological thymocyte development, with an interplay between TCR and glucocorticoid receptor (GR) signaling determining the T-lymphocyte selection process. We performed an shRNA screen in vitro and in vivo in T-ALL cell lines and patient derived xenograft (PDX) samples to identify vulnerabilities in the pTCR/TCR pathway and identified a critical role for the kinase LCK in cell proliferation. LCK knockdown or inhibition with dasatinib (DAS) caused cell cycle arrest. Combination of DAS with dexamethasone (DEX) resulted in significant drug synergy leading to cell death. The efficacy of this drug combination was underscored in a randomized phase II-like murine trial, recapitulating an early phase human clinical trial. T-ALL expansion in immunocompromised mice was significantly impaired using this drug combination, relative to mice receiving control vehicle or single drug treatment, highlighting the immediate clinical ...Continue Reading

References

Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·C A Jamieson, K R Yamamoto
Sep 27, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John M GoldbergBarbara L Asselin
May 5, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gertjan J L KaspersAnjo J P Veerman
Jun 15, 2005·British Journal of Haematology·C D MitchellUNKNOWN Medical Research Council Childhood Leukaemia Working Party
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lei YangMary V Relling
Aug 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elizabeth A RaetzWilliam L Carroll
Feb 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bella S GuerrouahenSeth J Corey
Feb 12, 2010·Leukemia·K C LeeM J Bijlmakers
Jun 15, 2010·Progress in Brain Research·Lindsay K Smith, John A Cidlowski
Oct 16, 2010·The Lancet Oncology·Hiroto Inaba, Ching-Hon Pui
Oct 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Thomas SerwoldIrving L Weissman
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ching-Hon PuiRobert J Arceci
Jun 8, 2012·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Alice M NyakerigaAnjali Joshi
May 7, 2016·Bioinformatics·Giovanni Y Di VeroliDuncan I Jodrell
Apr 2, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dane R Liston, Myrtle Davis
May 31, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William B SlaytonStephen P Hunger

❮ Previous
Next ❯

Citations

Jun 4, 2021·Cancer Medicine·Marcela B MansurFrederik W van Delft
May 5, 2021·British Journal of Haematology·Rachael PocockMarc R Mansour

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.